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SUMMARY Alopecia areata (AA) is a common form of localized, 
non-scarring hair loss. It is characterized by the loss of hair in 
patches, total loss of scalp hair (alopecia totalis), or total loss 
of body hair (alopecia universalis). The etiopathogenesis of the 
disease is still unclear, but there is evidence that autoimmunity 
and endocrine dysfunction may be involved. The aim of this 
study was to determine whether AA is statistically associated with 
thyroid autoimmunity. In this retrospective epidemiologic study, we 
compared the frequency of thyroid autoantibodies (thyroglobulin 
antibody, TgAb, and thyroid peroxidase antibody, TPAb) ATPO) in 
70 AA patients and 30 healthy volunteers. Thyroid autoantibodies 
and thyroid hormones (thyroxine (T4), triiodothyronine (T3) 
and thyroid stimulating hormone (TSH)) were measured in all 
subjects. Thyroid functional abnormalities were found in 8 (11.4%) 
AA patients. Positive autoimmune antibodies were associated 
with AA in 18 (25.7%) patients, with no significant association 
between the disease severity and presence of these antibodies. 
The frequency of thyroid autoantibodies was significantly higher 
in AA patients than in healthy controls (25.7% vs. 3.3%; p<0.05). 
Our findings pointed to a significant association between AA 
and thyroid autoimmunity and showed the tests to detect thyroid 
autoantibodies to be relevant in AA patients.
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INTRodUCTIoN
Alopecia areata (AA) is a common disease, 
present in 1% of the general population and 0.7%-
4% of patients presenting to dermatologic clin-
ics (1,2). It is characterized by the loss of hair in 
patches, total loss of scalp hair (alopecia totalis), 
or total loss of body hair (alopecia universalis). 
In contrast to scarring hair loss induced by other 
chronic, inflammatory skin diseases, lesional hair 
follicles in AA generally do not scar and can re-
grow. The nail matrix may also be affected, result-
ing in pits in the nail plate or even more severe 
nail dystrophy (3). The etiopathogenesis of the 
disease is still unclear, but there is evidence that 
autoimmunity and endocrine dysfunction may be 
involved (4-6). The association of AA with other 
autoimmune processes, such as autoimmune thy-
roiditis and vitiligo, has been widely reported and 
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tion of autoimmunity in the pathogenesis of AA. 
Also, there is a lack of agreement on the overall 
prevalence of thyroid disease and thyroid func-
tion abnormalities in AA; in literature reports, the 
prevalence of thyroid disease in AA patients varies 
from 8% to 28% (1,2).
The aim of this study was to determine whether 
AA is statistically significantly associated with thy-
roid autoimmunity.
PATIeNTS ANd MeTHodS
In this retrospective epidemiologic study, we 
compared the frequency of thyroid autoantibod-
ies (thyroglobulin antibody, TgAb, and thyroid per-
oxidase antibody, TPAb) in 70 AA patients and 30 
healthy adult volunteers. A detailed history and ex-
amination were taken in all study subjects, includ-
ing patient age, age at onset, duration of disease, 
associated diseases, history of thyroid disorders, 
and the extent and severity of disease. The diag-
nosis of AA was made on clinical grounds. Thyroid 
autoantibodies and thyroid hormones (thyroxine 
(T4), triiodothyronine (T3) and thyroid stimulating 
hormone (TSH)) were measured in all subjects. 
Total T4 (normal range: 70-180 nmol/L) and total 
T3 (normal range: 1.3-3.3 nmol/L) were measured 
by use of radioimmunoassay (RIA); TSH (normal 
range: 0.3-4.2 mlU/L) was determined by use of 
immunoradiometric assay (IRMA) (BRAHMS Ak-
tiengesellschaft, Hennigsdorf, Germany). Serum 
levels of TgAb (threshold value: 115 IU/mL) and 
TPAb (borderline value: 34 IU/mL) were measured 
by use of electrochemiluminescence immunoas-
say (ECLIA) according to standard protocols (CO-
BAS, Roche Diagnostics GmbH, Mannheim, Ger-
many).
Statistical comparisons were performed using 
χ2-test. Data were considered statistically signifi-
cant at p<0.05. 
ReSULTS ANd dISCUSSIoN
There were 38 (54.3%) female and 32 (45.7%) 
male patients, age range 4-72 (mean 31.2) years. 
Of them, there were 16 (22.9%) patients with uni-
locular lesions, 44 (62.8) with multilocular lesions, 
6 (8.6%) with alopecia totalis and 4 (5.7%) with 
alopecia universalis. Patient age at the disease 
onset ranged widely from 4 to 67 years. A fam-
ily history of the same disease was present in 7 
(10%) patients. The duration of AA ranged from 1 
to 172 months. A family history of thyroid disease 
was recorded in 5 (7.1%) patients.
Control group consisted of 30 generally healthy 
subjects (16 female and 14 male, median age 34.7 
years).
Thyroid functional abnormalities were found 
in 8 (11.4 %) patients. Positive thyroid antibodies 
were associated with AA in 18 (25.7%) patients 
with no significant association between the dis-
ease severity and presence of these antibodies. In 
the control group, one (3.3%) subject had positive 
thyroid antibodies (Table 1).
The frequency of thyroid autoantibodies was 
significantly higher in AA patients than in healthy 
controls (25.7% vs. 3.3%; p<0.05) (Fig. 1).
AA is hypothesized to be an autoimmune, or-
gan specific T-cell mediated reaction directed 
against the human hair follicle. Although the skin 
is the primary location of the clinical phenotype, 
the determination of disease expression involves 
a complex interplay between differen  inflamma-
tory cell subsets in the skin, skin draining lymph 
nodes, and spleen of affected individuals (7). The 
autoimmune etiology has also been proposed on 
Form of alopecia areata n %
Alopecia unilocularis 4 5.7
Alopecia multilocularis 11 15.7
Alopecia totalis 2 2.9
Alopecia universalis 1 1.4
Total 18 25.7
Table 1. The frequency of positive thyroglobulin 
antibody (TgAb) and thyroid peroxidase antibody 
(TPAb) in different forms of alopecia areata
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the basis of its association with various autoim-
mune diseases, the presence of autoantibodies 
and various underlying immune abnormalities at 
the affected sites of these patients (4,8). One of 
the main associations is with thyroid abnormali-
ties. This association was further supported by an 
increased incidence of abnormal thyroid function 
tests and/or presence of thyroid autoantibodies 
found in many studies (9-12).
Our study clearly demonstrated that antithyroid 
autoantibodies were significantly increased in AA 
patients (25.7%) in comparison to healthy subjects 
(3.3%). Patients with thyroid disease were on an 
average older, reported longer duration of disease 
and were female, but the results were not statisti-
cally significant. These results are consistent with 
a clinical study performed by Seyrafi et al. They 
analyzed serum TgAb level in 123 Iranian patients 
with AA and found it to be elevated in 29.3% of 
study patients (13). Our findings are similar to the 
study of Nanda et al., who also recorded a sig-
nificant increase in serum TgAb (14%) in children 
with AA (14). Kurtev and Ilev observed the pres-
ence of thyroid autoantibodies in even 39.5% of 
AA patients (15). 
AA offers many benefits as a model for the 
study of autoimmunity, in that it can be used to 
identify the contributing roles of immunogenetics 
and neuroendocrine factors in the initiation and 
propagation of autoimmune disease (3).
CoNCLUSIoN
The study revealed a significant association 
between AA and thyroid autoimmunity and showed 
the tests used to detect thyroid autoantibodies to 
be relevant in patients with AA. Further explora-
tion of this relationship in clinical setting and at a 
molecular level may help in the understanding of 
the pathogenesis of both diseases.
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